APA引用形式

Sundar, R., Huang, K. K., Qamra, A., Kim, K. -., Kim, S. T., Kang, W. K., . . . Tan, P. (2019). Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer. Ann Oncol.

シカゴスタイル引用形

Sundar, R., K K. Huang, A. Qamra, K -M Kim, S T. Kim, W K. Kang, A L K. Tan, J. Lee, , P. Tan. "Epigenomic Promoter Alterations Predict for Benefit From Immune Checkpoint Inhibition in Metastatic Gastric Cancer." Ann Oncol 2019.

MLA引用形式

Sundar, R., et al. "Epigenomic Promoter Alterations Predict for Benefit From Immune Checkpoint Inhibition in Metastatic Gastric Cancer." Ann Oncol 2019.